Vicky A. Cameron

6.0k total citations
124 papers, 3.8k citations indexed

About

Vicky A. Cameron is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vicky A. Cameron has authored 124 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 33 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vicky A. Cameron's work include Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (11 papers) and Cancer-related molecular mechanisms research (11 papers). Vicky A. Cameron is often cited by papers focused on Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (11 papers) and Cancer-related molecular mechanisms research (11 papers). Vicky A. Cameron collaborates with scholars based in New Zealand, United States and Singapore. Vicky A. Cameron's co-authors include Mark Richards, Leigh J. Ellmers, Chris Frampton, Anna P. Pilbrow, Eric A. Espiner, Richard W. Troughton, Wylie Vale, Timothy G. Yandle, Paul E. Sawchenko and M. Gary Nicholls and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Vicky A. Cameron

120 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vicky A. Cameron New Zealand	35	1.4k	1.2k	497	433	376	124	3.8k
Martin Andrassy Germany	23	737 0.5×	831 0.7×	467 0.9×	284 0.7×	332 0.9×	49	3.3k
Yue Qi China	39	1.2k 0.8×	871 0.7×	750 1.5×	565 1.3×	794 2.1×	194	4.8k
Hong Ji United States	27	879 0.6×	780 0.6×	825 1.7×	399 0.9×	329 0.9×	67	3.1k
Alan B. Weder United States	34	1.6k 1.2×	1.0k 0.9×	790 1.6×	579 1.3×	442 1.2×	94	4.7k
Barbara T. Alexander United States	44	2.0k 1.4×	741 0.6×	585 1.2×	717 1.7×	996 2.6×	121	7.0k
Kyosuke Takeshita Japan	35	981 0.7×	1.7k 1.4×	290 0.6×	615 1.4×	517 1.4×	141	4.4k
Toru Nabika Japan	29	827 0.6×	980 0.8×	662 1.3×	761 1.8×	433 1.2×	172	3.5k
Yanbin Dong United States	37	615 0.4×	1.2k 0.9×	599 1.2×	965 2.2×	230 0.6×	163	4.2k
P. Schuff‐Werner Germany	29	730 0.5×	432 0.4×	303 0.6×	443 1.0×	766 2.0×	121	3.5k
Mansoureh Eghbali United States	39	1.6k 1.1×	1.9k 1.6×	477 1.0×	382 0.9×	549 1.5×	114	5.0k

Countries citing papers authored by Vicky A. Cameron

Since Specialization

Citations

This map shows the geographic impact of Vicky A. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky A. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky A. Cameron more than expected).

Fields of papers citing papers by Vicky A. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky A. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky A. Cameron. The network helps show where Vicky A. Cameron may publish in the future.

Co-authorship network of co-authors of Vicky A. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky A. Cameron. A scholar is included among the top collaborators of Vicky A. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky A. Cameron. Vicky A. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Earle, Nikki, Anna P. Pilbrow, Katrina Poppe, et al.. (2024). Pharmacogenomic Variation in Antiplatelet and Anticoagulant Medication Response: Data from the Multi-Ethnic New Zealand Study of Acute Coronary Syndromes. Heart Lung and Circulation. 33. S71–S71.

Pilbrow, Anna P., Chris Frampton, Vicky A. Cameron, et al.. (2024). Plasma Soluble Fms-Like Tyrosine Kinase-1, Placental Growth Factor, and Vascular Endothelial Growth Factor System Gene Variants as Predictors of Survival in Heart Failure. European Journal of Heart Failure. 26(8). 1804–1813. 1 indexed citations

Gibbs, Simon, Gregory T. Jones, Nikki Earle, et al.. (2024). DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ. European Heart Journal. 45(Supplement_1). 2 indexed citations

Pilbrow, Anna P., Torsten Kleffmann, John W. Pickering, et al.. (2023). Comparison of SPEED, S-Trap, and In-Solution-Based Sample Preparation Methods for Mass Spectrometry in Kidney Tissue and Plasma. International Journal of Molecular Sciences. 24(7). 6290–6290. 5 indexed citations

Scott-Thomas, Amy, Priyanka Sinha, Anna P. Pilbrow, et al.. (2022). Hydrogen Sulfide and Substance P Levels in Patients with Escherichia coli and Klebsiella pneumoniae Bacteraemia. International Journal of Molecular Sciences. 23(15). 8639–8639. 4 indexed citations

Ward, Zoë, Sebastian Schmeier, John F. Pearson, et al.. (2022). Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma. Cells. 11(20). 3191–3191. 11 indexed citations

Palmer, Barry R., Chris Frampton, Anna P. Pilbrow, et al.. (2021). Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. PLoS ONE. 16(7). e0254206–e0254206. 6 indexed citations

Stamp, Lisa K., Vicky A. Cameron, Tim B. F. Woodfield, et al.. (2021). Impact of COVID‐19 on health research in New Zealand: a case study of a research‐intensive campus. Journal of the Royal Society of New Zealand. 51(S1). 8 indexed citations

Ward, Zoë, John F. Pearson, Sebastian Schmeier, Vicky A. Cameron, & Anna P. Pilbrow. (2021). Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease. RNA Biology. 18(12). 2055–2072. 18 indexed citations

10.

Legget, Malcolm E., Vicky A. Cameron, Nikki Earle, et al.. (2021). The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and Methodology. SHILAP Revista de lepidopterología. 11(2). 84–97. 3 indexed citations

11.

Ward, Zoë, Sebastian Schmeier, Louis Saddic, et al.. (2021). Novel and Annotated Long Noncoding RNAs Associated with Ischemia in the Human Heart. International Journal of Molecular Sciences. 22(21). 11324–11324. 6 indexed citations

12.

Lassé, Moritz, et al.. (2020). Abstract 16095: Plasma NT-proBNP Concentrations are Two-fold Lower in Pacific versus European Population Samples: Evidence for Glycosylation Impacting Assay Detection and/or ProBNP Processing. Circulation. 142(Suppl_3). 2 indexed citations

13.

Ellmers, Leigh J., Anna P. Pilbrow, Chris Frampton, et al.. (2020). Hydrogen Sulfide Treatment Improves Post-Infarct Remodeling and Long-Term Cardiac Function in CSE Knockout and Wild-Type Mice. International Journal of Molecular Sciences. 21(12). 4284–4284. 23 indexed citations

14.

Pilbrow, Anna P., Chris Frampton, Mark Richards, Richard W. Troughton, & Vicky A. Cameron. (2014). Abstract 18066: Elevated Levels of Circulating MicroRNA-223, MicroRNA-127 and MicroRNA-146a are Associated with Risk of Near Future Cardiovascular Events in Asymptomatic Individuals. Circulation. 130. 1 indexed citations

15.

Ellis, Katrina L., Vicky A. Cameron, Richard W. Troughton, et al.. (2013). Circulating microRNAs as Candidate Markers to Distinguish Heart Failure in Breathless Patients. European Journal of Heart Failure. 15(10). 1138–1147. 140 indexed citations

16.

Pilbrow, Anna P., Lasse Folkersen, John F. Pearson, et al.. (2012). The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues. PLoS ONE. 7(6). e39574–e39574. 33 indexed citations

17.

Pitama, Suzanne, J. Elisabeth Wells, Paul Robertson, et al.. (2011). A Kaupapa Māori approach to a community cohort study of heart disease in New Zealand. Australian and New Zealand Journal of Public Health. 35(3). 249–255. 18 indexed citations

18.

Pilbrow, Anna P., John F. Pearson, Christine S. Moravec, et al.. (2008). Abstract 1812: The Chromosome 9p21.3 Coronary Artery Disease Risk Locus is Associated with Altered Cardiac Gene Expression in Individuals without Overt Cardiac Abnormality. Circulation. 118. 1 indexed citations

19.

Palmer, Barry R., Anna P. Pilbrow, Timothy G. Yandle, et al.. (2003). Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. Journal of the American College of Cardiology. 41(5). 729–736. 58 indexed citations

20.

Cameron, Vicky A., et al.. (1996). The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta.. Endocrinology. 137(3). 817–824. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact